ATRX and central nervous system cancer: In cases of IDH‐mutant gliomas with intact 1p/19q or loss of ATRX as a surrogate in a child, adolescent, or young adult, a heightened level of suspicion is warranted, particularly if the histology exhibits high‐grade features.